202 related articles for article (PubMed ID: 36408173)
1. Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation.
Aoki Y; Han Q; Tome Y; Yamamoto J; Kubota Y; Masaki N; Obara K; Hamada K; Wang JD; Inubushi S; Bouvet M; Clarke SG; Nishida K; Hoffman RM
Front Oncol; 2022; 12():1009548. PubMed ID: 36408173
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes and Methionine Addiction of Cancer: Role of
Aoki Y; Han Q; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(2):165-170. PubMed ID: 36870694
[TBL] [Abstract][Full Text] [Related]
3. Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.
Yamamoto J; Aoki Y; Inubushi S; Han Q; Hamada K; Tashiro Y; Miyake K; Matsuyama R; Bouvet M; Clarke SG; Endo I; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(1):12-18. PubMed ID: 34949655
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Aoki Y; Kubota Y; Han Q; Masaki N; Obara K; Bouvet M; Chawla SP; Tome Y; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):679-685. PubMed ID: 38035708
[TBL] [Abstract][Full Text] [Related]
5. Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Bouvet M; Nishida K; Hoffman RM
Biochem Biophys Rep; 2021 Dec; 28():101177. PubMed ID: 34877414
[TBL] [Abstract][Full Text] [Related]
6. Linkage of methionine addiction, histone lysine hypermethylation, and malignancy.
Yamamoto J; Inubushi S; Han Q; Tashiro Y; Sugisawa N; Hamada K; Aoki Y; Miyake K; Matsuyama R; Bouvet M; Clarke SG; Endo I; Hoffman RM
iScience; 2022 Apr; 25(4):104162. PubMed ID: 35434545
[TBL] [Abstract][Full Text] [Related]
7. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.
Yamamoto J; Han Q; Inubushi S; Sugisawa N; Hamada K; Nishino H; Miyake K; Kumamoto T; Matsuyama R; Bouvet M; Endo I; Hoffman RM
Biochem Biophys Res Commun; 2020 Dec; 533(4):1034-1038. PubMed ID: 33019978
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells.
Holtz AG; Lowe TL; Aoki Y; Kubota Y; Hoffman RM; Clarke SG
PLoS One; 2023; 18(12):e0296291. PubMed ID: 38134182
[TBL] [Abstract][Full Text] [Related]
9. Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells.
Yamamoto J; Aoki Y; Han Q; Sugisawa N; Sun YU; Hamada K; Nishino H; Inubushi S; Miyake K; Matsuyama R; Bouvet M; Endo I; Hoffman RM
Anticancer Res; 2021 Feb; 41(2):641-643. PubMed ID: 33517268
[TBL] [Abstract][Full Text] [Related]
10. Deletion of
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564
[TBL] [Abstract][Full Text] [Related]
11. Effective Metabolic Targeting of Human Osteosarcoma Cells
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
[TBL] [Abstract][Full Text] [Related]
12. Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Wu NF; Samonte C; Wu J; Hozumi C; Obara K; Kubota Y; Aoki Y; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2598-2603. PubMed ID: 36309364
[TBL] [Abstract][Full Text] [Related]
13. Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Samonte C; Wu NF; Hozumi C; Wu J; Obara K; Kubota Y; Aoki Y; Bouvet M; Hoffman RM
Anticancer Res; 2022 Nov; 42(11):5217-5222. PubMed ID: 36288875
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
15. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871
[TBL] [Abstract][Full Text] [Related]
16. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
[TBL] [Abstract][Full Text] [Related]
17. Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.
Aoki Y; Yamamoto J; Tome Y; Hamada K; Masaki N; Inubushi S; Tashiro Y; Bouvet M; Endo I; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2021; 18(6):715-721. PubMed ID: 34697064
[TBL] [Abstract][Full Text] [Related]
18. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.
Luu HH; Kang Q; Park JK; Si W; Luo Q; Jiang W; Yin H; Montag AG; Simon MA; Peabody TD; Haydon RC; Rinker-Schaeffer CW; He TC
Clin Exp Metastasis; 2005; 22(4):319-29. PubMed ID: 16170668
[TBL] [Abstract][Full Text] [Related]
19. Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
Ardjmand D; Kubota Y; Sato M; Han Q; Mizuta K; Morinaga S; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):929-933. PubMed ID: 38423628
[TBL] [Abstract][Full Text] [Related]
20. Reduction of invasion and cell stemness and induction of apoptotic cell death by Cinnamomum cassia extracts on human osteosarcoma cells.
Lin CY; Hsieh YS; Chu SC; Hsu LS; Huang SC; Chen PN
Environ Toxicol; 2022 Jun; 37(6):1261-1274. PubMed ID: 35146896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
